Breaking News
Get 40% Off 0
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March. Read full update
Close

Enanta Pharmaceuticals Inc (ENTA)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Enanta's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
13.21 -1.39    -9.52%
04:22:01 - Real-time Cboe. Currency in USD ( Disclaimer )
  • Volume: 196,687
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 11.60 - 13.21
Type:  Equity
Market:  United States
Enanta 13.21 -1.39 -9.52%

ENTA Recent Sentiments

 
This page features our user's sentiments regarding the Enanta Pharmaceuticals Inc stock. They are displayed on both charts of different time periods and in a detailed table.
Start Date Username Call Open Rate End Date Chg. %
May 09, 2023 Jesus Garcia   24.48 May 23, 2023 @ 28.14 +14.95%
May 19, 2022 Andreas Schatz   42.07 Jun 10, 2022 @ 40.86 -2.88%
Dec 20, 2021 Grzegorz Lis   78.69 Jan 14, 2022 @ 60.00 +23.75%
Oct 20, 2021 José Morales Henares   71.85 Nov 12, 2021 @ 91.08 +26.76%
Oct 19, 2021 Александр Ельчанинов   69.47 Nov 12, 2021 @ 91.08 +31.11%
Oct 07, 2021 frida Bogaert   65.35 Oct 11, 2021 @ 70.40 +7.73%
Sep 28, 2021 mark pernik   56.85 Oct 22, 2021 @ 73.97 +30.11%
Aug 17, 2021 Александр Тютчев   47.35 Aug 23, 2021 @ 53.18 -12.31%
Aug 17, 2021 Александр Тютчев   47.35 Aug 23, 2021 @ 53.18 -12.31%
Feb 08, 2021 Сергей Евтихов   54.67 Mar 05, 2021 @ 51.44 -5.91%
Jan 11, 2021 Alexander Markakis   47.50 Feb 05, 2021 @ 53.09 +11.77%
Dec 02, 2020 сергей Иванов   41.45 Dec 25, 2020 @ 42.90 -3.50%
Oct 20, 2020 kirill pankinov   43.68 Nov 07, 2020 @ 44.28 -1.37%
Oct 20, 2020 kirill pankinov   43.45 Oct 20, 2020 @ 43.45 0.00%
Aug 26, 2020 Андрей Черных   50.45 Sep 18, 2020 @ 46.16 +8.50%
May 29, 2020 Shaul Shalit   50.06 Jun 19, 2020 @ 49.16 -1.80%
May 27, 2020 Дмитрий Пылев   50.52 Jun 19, 2020 @ 49.16 -2.69%
Apr 29, 2020 prosto Walerok   49.46 May 22, 2020 @ 55.30 +11.81%
Apr 28, 2020 Алексей Семенюк   50.73 May 22, 2020 @ 55.30 +9.01%
Nov 20, 2019 磊 苏   62.62 Nov 22, 2019 @ 63.51 -1.42%
Oct 14, 2019 Georgios Skarvelis   58.98 Nov 08, 2019 @ 63.51 +7.68%
Sep 26, 2019 BEAU HARRISON   60.45 Oct 18, 2019 @ 59.71 -1.22%
Sep 26, 2019 Goooch Trahard   60.90 Oct 01, 2019 @ 61.55 +1.07%
Sep 26, 2019 Hubertus Schmiedt   58.15 Oct 09, 2019 @ 57.40 -1.29%
Sep 26, 2019 Geo Sp   59.50 Oct 18, 2019 @ 59.71 -0.35%
Jul 24, 2019 Илья Гаврилов   81.88 Jul 29, 2019 @ 77.34 -5.54%
Feb 28, 2019 עזרא ערבה   102.78 Mar 22, 2019 @ 95.41 -7.17%
Feb 08, 2019 Anastacia Rodrigues   91.74 Mar 10, 2019 @ 99.30 +8.24%
Oct 08, 2018 Ross Keiser   77.31 Nov 07, 2018 @ 33.94 -56.10%
Aug 15, 2018 Ey Be   87.63 Sep 14, 2018 @ 90.58 -3.37%
Aug 09, 2018 Anthony Gomes   95.10 Sep 08, 2018 @ 87.91 -7.56%
Jul 13, 2018 אלעד בוטח   123.25 Aug 12, 2018 @ 93.95 -23.77%
Mar 19, 2018 Charles Criswell   87.24 Apr 18, 2018 @ 87.43 +0.22%
Feb 12, 2018 Charles Criswell   73.42 Mar 14, 2018 @ 84.89 +15.62%
Nov 17, 2017 Fred Smith   48.54 Dec 17, 2017 @ 55.83 +15.02%
Aug 07, 2017 Fiodor silin   38.56 Sep 06, 2017 @ 42.85 +11.13%
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ENTA Comments

Write your thoughts about Enanta Pharmaceuticals Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email